{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:45:29Z","timestamp":1785386729493,"version":"3.55.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background and aims<\/jats:title><jats:p>IgG4-related cholangitis (IRC) is the hepatobiliary manifestation of IgG4-related disease, a systemic B cell-driven fibro-inflammatory disorder. Four autoantigens have recently been described in IgG4-RD: annexin A11, galectin-3, laminin 511-E8, and prohibitin 1. We have previously reported a protective role of annexin A11 and laminin 511-E8 in human cholangiocytes against toxic bile acids. Here, we explored the potentially protective role of the carbohydrate-binding lectin galectin-3 and the scaffold proteins prohibitins 1 and 2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Anti-galectin-3, anti-prohibitin 1 and 2 autoantibody positivity in IRC and healthy and disease (primary sclerosing cholangitis (PSC)) control sera was assessed by ELISA\/liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS). Human H69 cholangiocytes were subjected to short hairpin RNA (shRNA) knockdown targeting galectin-3 (<jats:italic>LGALS3<\/jats:italic>), prohibitin 1 (<jats:italic>PHB1<\/jats:italic>), and prohibitin 2 (<jats:italic>PHB2<\/jats:italic>). H69 cholangiocytes were also exposed to recombinant galectin-3, the inhibitor GB1107, recombinant prohibitin 1, and the pan-prohibitin inhibitor rocaglamide. Protection against bile acid toxicity was assessed by intracellular pH (pH<jats:sub>i<\/jats:sub>) measurements using BCECF-AM, 22,23-<jats:sup>3<\/jats:sup>H-glycochenodeoxycholic acid (<jats:sup>3<\/jats:sup>H-GCDC) influx, and GCDC-induced apoptosis using Caspase-3\/7 assays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Anti-galectin-3 autoantibodies were detected in 13.5% of individuals with IRC but not in PSC. Knockdown of <jats:italic>LGALS3<\/jats:italic> and galectin-3 inhibition with GB1107 did not affect pH<jats:sub>i<\/jats:sub>, whereas recombinant galectin-3 incubation lowered pH<jats:sub>i<\/jats:sub>. <jats:italic>LGALS3<\/jats:italic> knockdown increased GCDC-influx but not GCDC-induced apoptosis. GB1107 reduced GCDC-influx and GCDC-induced apoptosis. Recombinant galectin-3 tended to decrease GCDC-influx and GCDC-induced apoptosis. Anti-prohibitin 1 autoantibodies were detected in 61.5% and 35.7% of individuals with IRC and PSC, respectively. Knockdown of <jats:italic>PHB1<\/jats:italic>, combined <jats:italic>PHB1\/2<\/jats:italic> KD, treatment with rocaglamide, and recombinant prohibitin 1 all lowered pH<jats:sub>i<\/jats:sub>. Knockdown of <jats:italic>PHB1<\/jats:italic>, <jats:italic>PHB2<\/jats:italic>, or combined <jats:italic>PHB1\/2<\/jats:italic> did not alter GCDC-influx, yet knockdown of <jats:italic>PHB1<\/jats:italic> increased GCDC-induced apoptosis. Conversely, rocaglamide reduced GCDC-influx but did not attenuate GCDC-induced apoptosis. Recombinant prohibitin 1 did not affect GCDC-influx or GCDC-induced apoptosis. Finally, anti-galectin-3 and anti-prohibitin 1 autoantibody pretreatment did not lead to increased GCDC-influx.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A subset of individuals with IRC have autoantibodies against galectin-3 and prohibitin 1. Gene-specific knockdown, pharmacological inhibition, and recombinant protein substitution did not clearly disclose a protective role of these autoantigens in human cholangiocytes against toxic bile acids. The involvement of these autoantibodies in processes surpassing epithelial secretion remains to be elucidated.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1251134","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T16:10:12Z","timestamp":1706199012000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids"],"prefix":"10.3389","volume":"14","author":[{"given":"Remco","family":"Kersten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Trampert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowiek M.","family":"Hubers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Tolenaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmjan R.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan F. J.","family":"van de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00529-y","article-title":"IgG4-related diseases of the digestive tract","volume":"19","author":"L\u00f6hr","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum igg4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26977","article-title":"Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0036-5","article-title":"IgG4-associated cholangitis in patients resected for presumed perihilar cholangiocarcinoma: a 30-year tertiary care experience","volume":"113","author":"Roos","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24487","article-title":"Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma","volume":"54","author":"Oseini","year":"2011","journal-title":"Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26232","article-title":"Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis","volume":"57","author":"Maillette de Buy Wenniger","year":"2013","journal-title":"Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314548","article-title":"Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease","volume":"67","author":"Hubers","year":"2018","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","article-title":"Identification of galectin-3 as an autoantigen in patients with IgG4-related disease","volume":"143","author":"Perugino","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq0997","article-title":"Laminin 511 is a target antigen in autoimmune pancreatitis","volume":"10","author":"Shiokawa","year":"2018","journal-title":"Sci Transl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125331","article-title":"Prohibitin is involved in patients with igG4 related disease","volume":"10","author":"Du","year":"2015","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.41140","article-title":"Disease severity linked to increase in autoantibody diversity in igG4-related disease","volume":"72","author":"Liu","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310336","article-title":"Pathogenicity of IgG in patients with IgG4-related disease","volume":"65","author":"Shiokawa","year":"2016","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.07.038","article-title":"On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease","volume":"1864","author":"Trampert","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.01.013","article-title":"Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1","volume":"195","author":"Niks","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","article-title":"The unique properties of IgG4 and its roles in health and disease","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/nyas.13561","article-title":"IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders","volume":"1413","author":"Huijbers","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605214","article-title":"Common denominators in the immunobiology of igG4 autoimmune diseases: what do glomerulonephritis, pemphigus vulgaris, myasthenia gravis, thrombotic thrombocytopenic purpura and autoimmune encephalitis have in common","volume":"11","author":"Koneczny","year":"2020","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.10.009","article-title":"Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection","volume":"76","author":"Herta","year":"2022","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)01523-9","article-title":"The IgG4-related cholangitis autoantigen laminin 511-E8 stabilizes the biliary bicarbonate umbrella in human cholangiocytes","volume":"77","author":"Trampert","year":"2022","journal-title":"J Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2005.12.046","article-title":"Requirement for galectin-3 in apical protein sorting","volume":"16","author":"Delacour","year":"2006","journal-title":"Curr Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12086","article-title":"pH-dependent recycling of galectin-3 at the apical membrane of epithelial cells","volume":"14","author":"Straube","year":"2013","journal-title":"Traffic"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2013.02.006","article-title":"Prohibitin ligands in cell death and survival: mode of action and therapeutic potential","volume":"20","author":"Thuaud","year":"2013","journal-title":"Chem Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27959","article-title":"Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1","volume":"62","author":"Barbier-Torres","year":"2015","journal-title":"Hepatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29533","article-title":"MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation","volume":"67","author":"Erice","year":"2018","journal-title":"Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","author":"Chazouilleres","year":"2022","journal-title":"J hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1994.266.6.G1060","article-title":"Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines","volume":"266","author":"Grubman","year":"1994","journal-title":"Am J Physiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00308-7","article-title":"Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes","volume":"36","author":"Seppen","year":"2002","journal-title":"J Hepatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)01423-4","article-title":"Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data","volume":"339","author":"Ramakers","year":"2003","journal-title":"Neurosci Lett"},{"key":"B37","doi-asserted-by":"publisher","first-page":"100385","DOI":"10.1016\/j.jhepr.2021.100385","article-title":"Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas","volume":"3","author":"Hubers","year":"2021","journal-title":"JHEP Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10295-013-1235-0","article-title":"Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells","volume":"40","author":"Berlec","year":"2013","journal-title":"J Ind Microbiol Biotechnol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-002-8437-3","article-title":"The role of glycosylation in protein antigenic properties","volume":"59","author":"Lisowska","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2015.05.004","article-title":"Recycling of galectin-3 in epithelial cells","volume":"94","author":"H\u00f6nig","year":"2015","journal-title":"Eur J Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.213199","article-title":"Galectin-3 modulates the polarized surface delivery of \u03b21-integrin in epithelial cells","volume":"131","author":"H\u00f6nig","year":"2018","journal-title":"J Cell Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.211","article-title":"Galectin-3 regulates intracellular trafficking of EGFR through Alix and promotes keratinocyte migration","volume":"132","author":"Liu","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2007.00539.x","article-title":"Apical sorting by galectin-3-dependent glycoprotein clustering","volume":"8","author":"Delacour","year":"2007","journal-title":"Traffic"},{"key":"B44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/glycob\/cwj035","article-title":"Exploring the role of galectin 3 in kidney function: a genetic approach","volume":"16","author":"Bichara","year":"2006","journal-title":"Glycobiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-005-0801-y","article-title":"On the role of galectin-3 in cancer apoptosis","volume":"10","author":"Nakahara","year":"2005","journal-title":"Apoptosis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.0.CO;2-N","article-title":"Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties","volume":"85","author":"Matarrese","year":"2000","journal-title":"Int J Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.426445","article-title":"Epigenetic regulation of galectin-3 expression by \u03b21 integrins promotes cell adhesion and migration","volume":"287","author":"Margadant","year":"2012","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607465103","article-title":"Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels","volume":"103","author":"Huber","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002339200","article-title":"Prohibitins, stomatins, and plant disease response genes compose a protein superfamily that controls cell proliferation, ion channel regulation, and death","volume":"275","author":"Nadimpalli","year":"2000","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/s0300-9084(02)00027-5","article-title":"Prohibitin and prohibitone are contained in high-molecular weight complexes and interact with alpha-actinin and annexin A2","volume":"84","author":"Bacher","year":"2002","journal-title":"Biochimie"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03475-1","article-title":"Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases","volume":"77","author":"Wang","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29013","article-title":"Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines)","volume":"137","author":"Li-Weber","year":"2015","journal-title":"Int J Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-015-1143-z","article-title":"Multifaceted role of prohibitin in cell survival and apoptosis","volume":"20","author":"Peng","year":"2015","journal-title":"Apoptosis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.4049\/jimmunol.172.1.493","article-title":"Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection","volume":"172","author":"Acosta-Rodr\u00edguez","year":"2004","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1206747","article-title":"Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3 -\/- mice","volume":"82","author":"Oliveira","year":"2007","journal-title":"J Leukoc Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/glycob\/cwt026","article-title":"Lack of galectin-1 or galectin-3 alters B cell deletion and anergy in an autoantibody transgene model","volume":"23","author":"Clark","year":"2013","journal-title":"Glycobiol"},{"key":"B57","article-title":"CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis","volume":"63","author":"Fukumori","year":"2003","journal-title":"Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.2.778","article-title":"Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death","volume":"176","author":"Stillman","year":"2006","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903497106","article-title":"Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases","volume":"351","author":"Li","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B62","doi-asserted-by":"publisher","first-page":"105881","DOI":"10.1016\/j.biocel.2020.105881","article-title":"The therapeutic potential of galectin-3 inhibition in fibrotic disease","volume":"130","author":"Slack","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201646","article-title":"Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes","volume":"190","author":"Lucas","year":"2013","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708232200","article-title":"The PHB1\/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells","volume":"283","author":"Ross","year":"2008","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899429","article-title":"Targeting prohibitins at the cell surface prevents Th17-mediated autoimmunity","volume":"37","author":"Buehler","year":"2018","journal-title":"EMBO J"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00235","article-title":"T cell polarization toward T(H)2\/T(FH)2 and T(H)17\/T(FH)17 in patients with igG4-related disease","volume":"8","author":"Grados","year":"2017","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26447","article-title":"Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","author":"Katt","year":"2013","journal-title":"Hepatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23919","article-title":"Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice","volume":"52","author":"Ko","year":"2010","journal-title":"Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1251134\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T16:10:16Z","timestamp":1706199016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1251134\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2023.1251134"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1251134","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"article-number":"1251134"}}